ALX Oncology
Lisa Sauer has extensive experience in the pharmaceutical industry, mainly in regulatory affairs and quality assurance. Their most recent role is the Senior Vice President of Regulatory Affairs and Quality Assurance at ALX Oncology, starting in 2023.
Before that, Lisa worked as a Strategic Regulatory Consultant from 2022 to 2023, where they assisted companies with regulatory issues and strategic planning.
From 2005 to 2022, Lisa held various positions at Exelixis, including Senior Vice President, Vice President, Executive Director, Senior Director, Director, Associate Director, and Manager, all in regulatory affairs and quality assurance.
Lisa's career started at SuperGen in 1998, where they were a Manager of Regulatory Affairs.
Overall, Lisa's work experience spans over two decades, demonstrating their expertise and dedication in the field of regulatory affairs and quality assurance in the pharmaceutical industry.
Lisa Sauer holds a Bachelor of Science (B.S.) degree in Environmental Economics and Public Policy from the University of California, Berkeley.
ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.